Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chunhui Lan

10PUBLICATIONS
38CO-AUTHORS
Traditional Chinese medicine and treatmentsMedical bacteriologyPharmacogenomicsPreventative health careEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jul 07, 2026
Current Status of Diagnosis, Treatment, and Prevention of Helicobacter pylori Infection in China: A 2024-2025 National Multicenter Cross-Sectional Study.

|Jul 10, 2024
Long-term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomized controlled trial.

Jing-Tao Zhao, Yi Zhang, Xing-Wei Wang

|Aug 11, 2023
Efficacy and safety of vonoprazan-based dual therapy and esomeprazole-based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis.

Na-Yun Su, Qing Shi, Hao Mei

|May 09, 2023
Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China.

Jie Hu, Hao Mei, Na-Yun Su

|Jan 05, 2023
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy <i>versus</i> bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> infection: a multicenter, randomized controlled clinical trial.

Hao Mei, Yan Guo, Jing-Tao Zhao

|Jan 05, 2023
High-dose dual therapy <i>versus</i> culture-based susceptibility-guided therapy as a rescue regimen for <i>Helicobacter pylori</i> infection: a randomized controlled trial.

Zhe Zhao, Pei-Ying Zou, Na-Yun Su

Pageof 2

Frequent Collaborators

2 joint publications

Hao Mei

2 joint publications

Hong Lu

2 joint publications

Weihong Wang

2 joint publications

Jing-Tao Zhao

2 joint publications

Liya Zhou

2 joint publications

Zhe Zhao

2 joint publications

Yong Xie

1 joint publications

Jun Xia

1 joint publications

Jing-Yuan Fang

1 joint publications

Ming-Zhou Guo

Frequent Collaborators

2 joint publications

Hao Mei

2 joint publications

Hong Lu

2 joint publications

Weihong Wang

2 joint publications

Jing-Tao Zhao